Controversial online therapy to be used in childhood chronic fatigue syndrome trial

Support us and go ad-free

A clinical trial will use an online version of cognitive behavioural therapy (CBT) to treat children with chronic fatigue syndrome (CFS). CBT has proved controversial in the treatment of adult CFS due to its use in the heavily criticised PACE trial. The results of that trial proved highly contentious and are still at the centre of a heated debate.

Fighting CFS

CFS is a seriously debilitating illness with a range of symptoms which can vary in intensity. As well as chronic fatigue, other symptoms include poor mental function, muscle or joint pain, headaches and disturbed sleeping. It is also known as myalgic encephalomyelitis (ME) and is commonly referred to as ME/CFS in the UK.

The disease affects one in 50 UK children. Around one child in 100 misses at least one day a week from class. A small minority of people with ME/CFS can be very severely affected and end up bed-bound by the illness.

The FITNET-NHS trial will involve 734 children aged 11 to 17. It will use online cognitive behavioural therapy sessions to affect how children think of their illness. It also aims to reduce the amount of time they spend sleeping and advise on suitable activity levels.

Prof Esther Crawley, a children’s doctor at Bristol University, is leading the trial. She hopes to find out if online CBT consultations are beneficial for the patients and economical for NHS England, which is funding this study. Crawley says:

This illness is devastating. About 50% of teenagers are tired, but these children are different – they stop doing the stuff they want to do. The first thing they drop is socialising and fun things, then they drop school, so this is very different to teenagers just being tired.

Netherlands trial

The FITNET-NHS trial expands on another FITNET trial carried out in the Netherlands, on 135 adolescents. Six months after the trial finished 63% of patients receiving online CBT were reported to have no symptoms. This compared to 8% with no symptoms without therapy.

Read on...

Support us and go ad-free

Tom Kindlon has had ME/CFS for 27 years and is an expert on the literature published about the disease. He is concerned the news reports are not mentioning that the Dutch FITNET trial’s long term follow-up paper showed no significant difference between the therapy and control groups:

PACE trial

The use of CBT in ME/CFS treatment is seen as controversial by many due to its inclusion in a previous trial. The PACE trial has come under severe criticism for its bad science. It compared four therapies treating ME/CFS in adults. PACE was the largest and most expensive trial of its kind, and proved very influential in determining CFS care offered by health services worldwide. One therapy tested was CBT, which was in person and not online. It was compared to standard medical care (SMC) which consisted of the standard NHS treatment for ME/CFS.

Kindlon is also co-author of a paper that recalculated the controversial PACE trial results according to the original methods, as reported in The Canary. The full trial data, allowing analysis by the original methods, was only released by Queen Mary University after a long freedom of information battle through the courts.

The original PACE-published results showed CBT as having a 22% recovery rate, which was significantly higher than SMC at 7%. The calculations using the original methods give results of 7% recovery for CBT. This is not significantly higher than the 3% recovery calculated, using the orignal methods, for SMC. Kindlon and his colleagues stated:

Pending a comprehensive review or audit of trial data, it seems prudent that the published trial results should be treated as potentially unsound, as well as the medical texts, review articles and public policies based on those results.

Desperate need

The use of CBT in ME/CFS treatment often receives criticism due to the implication that ME/CFS is a psychological issue and not a biological one. The critics also claim too much time and money is spent on research into the psychological models of illness and not enough into biological ones.

But whether psychological or biologically based, an effective treatment for ME/CFS is desperately needed. Mary-Jane Willows from the ME/CFS charity AYME, said to the BBC:

It is a scandal, what other condition would you leave a child with – undiagnosed and untreated? And the trouble is the longer they are left, the more ill they become. This trial is hugely important, every day we are phoned by parents who are desperate to get treatment for their children.

Medical Research Council Prof Stephen Holgate thinks that ME/CFS is still not getting the attention it deserves, saying:

CFS/ME is an important disabling condition. It has been chronically underfunded for years; patients deserve high-quality research like this.

We won’t know the results of the FITNET-NHS trial until 2022. It will allow scientists to determine the long-term response to the treatment, and to present it in their initial publication. This should avoid the piecemeal publication of results seen with the Netherlands FITNET trial.

The scientists of the FITNET-NHS trial should use the PACE trial as an example of how not to carry out medical research. The last thing ME/CFS patients, and research, need is another clinical trial riddled by bad science.

Get Involved!

Support Invest in ME Research – charity campaigning for biomedical research into ME/CFS.

Support AllTrials – campaigning for all medical trials to be published.

Read David Tuller’s investigative report into the PACE trial.

Support The Canary so we can keep bringing you the news that matters.

Featured image via Flickr

Support us and go ad-free

We need your help to keep speaking the truth

Every story that you have come to us with; each injustice you have asked us to investigate; every campaign we have fought; each of your unheard voices we amplified; we do this for you. We are making a difference on your behalf.

Our fight is your fight. You’ve supported our collective struggle every time you gave us a like; and every time you shared our work across social media. Now we need you to support us with a monthly donation.

We have published nearly 2,000 articles and over 50 films in 2021. And we want to do this and more in 2022 but we don’t have enough money to go on at this pace. So, if you value our work and want us to continue then please join us and be part of The Canary family.

In return, you get:

* Advert free reading experience
* Quarterly group video call with the Editor-in-Chief
* Behind the scenes monthly e-newsletter
* 20% discount in our shop

Almost all of our spending goes to the people who make The Canary’s content. So your contribution directly supports our writers and enables us to continue to do what we do: speaking truth, powered by you. We have weathered many attempts to shut us down and silence our vital opposition to an increasingly fascist government and right-wing mainstream media.

With your help we can continue:

* Holding political and state power to account
* Advocating for the people the system marginalises
* Being a media outlet that upholds the highest standards
* Campaigning on the issues others won’t
* Putting your lives central to everything we do

We are a drop of truth in an ocean of deceit. But we can’t do this without your support. So please, can you help us continue the fight?

The Canary Support us

Comments are closed